Mouse Anti-IGFBP7 Recombinant Antibody (CBXF-1376) (CBMAB-F1308-CQ)

Yi, X., Zheng, X., Xu, H., Li, J., Zhang, T., Ge, P., ... & Ai, J. (2022). IGFBP7 and the tumor immune landscape: a novel target for immunotherapy in bladder cancer. Frontiers in Immunology, 13, 898493.

Ko, T., Nomura, S., Yamada, S., Fujita, K., Fujita, T., Satoh, M., ... & Komuro, I. (2022). Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis. Nature communications, 13(1), 3275.

Zhao, Q., Zhao, R., Song, C., Wang, H., Rong, J., Wang, F., ... & Xie, Y. (2021). Increased IGFBP7 expression correlates with poor prognosis and immune infiltration in gastric cancer. Journal of Cancer, 12(5), 1343.

Jin, L., Shen, F., Weinfeld, M., & Sergi, C. (2020). Insulin growth factor binding protein 7 (IGFBP7)-related cancer and IGFBP3 and IGFBP7 crosstalk. Frontiers in Oncology, 10, 727.

Huang, X., Hong, C., Peng, Y., Yang, S., Huang, L., Liu, C., ... & Xu, Y. (2019). The diagnostic value of serum IGFBP7 in patients with esophageal squamous cell carcinoma. Journal of Cancer, 10(12), 2687.

Fejzo, M. S., Fasching, P. A., Schneider, M. O., Schwitulla, J., Beckmann, M. W., Schwenke, E., ... & Mullin, P. M. (2019). Analysis of GDF15 and IGFBP7 in hyperemesis gravidarum support causality. Geburtshilfe und Frauenheilkunde, 79(04), 382-388.

Zhang, L., Lian, R., Zhao, J., Feng, X., Ye, R., Pan, L., ... & Cai, J. (2019). IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma. Cell & bioscience, 9(1), 1-13.

Fejzo, M. S., Sazonova, O. V., Sathirapongsasuti, J. F., Hallgrímsdóttir, I. B., Vacic, V., MacGibbon, K. W., ... & Mullin, P. M. (2018). Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nature communications, 9(1), 1178.

Johnson, A. C., & Zager, R. A. (2018). Mechanisms underlying increased TIMP2 and IGFBP7 urinary excretion in experimental AKI. Journal of the American Society of Nephrology: JASN, 29(8), 2157.

Januzzi Jr, J. L., Packer, M., Claggett, B., Liu, J., Shah, A. M., Zile, M. R., ... & Solomon, S. D. (2018). IGFBP7 (insulin-like growth factor–binding protein-7) and neprilysin inhibition in patients with heart failure. Circulation: Heart Failure, 11(10), e005133.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols